Filing Details

Accession Number:
0001225208-16-043153
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-12-14 12:09:36
Reporting Period:
2016-12-12
Filing Date:
2016-12-14
Accepted Time:
2016-12-14 12:09:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
9892 Bard C R Inc BCR Surgical & Medical Instruments & Apparatus (3841) 221454160
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1453458 M Sharon Luboff C/O C. R. Bard, Inc.
730 Central Avenue
Murray Hill NJ 07974
Group Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-12-12 6,000 $86.15 29,837 No 4 M Direct
Common Stock Disposition 2016-12-12 6,000 $219.00 23,837 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (Right to Buy) Disposition 2016-12-12 6,000 $0.00 6,000 $86.15
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
13,940 2020-12-08 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 69 Indirect 401(k) Plan
Footnotes
  1. Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan.
  2. Includes 130.992 shares acquired under the Company's Employee Stock Purchase Plan from February 6, 2016 to November 7, 2016.
  3. Share amount reduced pursuant to a qualified domestic relations order. Includes 0.167 shares acquired under the Company's 401(k) Plan from February 6, 2016 to November 4, 2016.
  4. Performance options granted under the 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
  5. Options fully vested upon achievement of certain performance criteria and are currently exercisable.